2016 SECIM P&F Projects

In 2016, SECIM awarded pilot & feasibility project funds to the following researchers:

• Dr. Sarah Borengasser, University of Colorado at Denver
  “Targeted Metabolomics for 1C Metabolites from Maternal Dried Blood Spot Samples
  Prior to and During Pregnancy”
• Dr. Fernando Bril, University of Florida
  “Identification of Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver
  Disease”
• Dr. Hans Ghayee, University of Florida
  “Metabolic Analysis of Human PCC/PGL Cancer Cells Reveals the Importance of
  Chromogranin-mediated Deacidification in Cancer Survival”
• Dr. John Hartman, University of Alabama at Birmingham
  “Integration of genetic and metabolic networks that influence cellular aging”
• Dr. Julie Johnson, University of Florida
  “Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics”
• Dr. Peter Kanetsky, Moffitt Cancer Center
  “Metabolomics of Cutaneous Malignant Melanoma”
• Dr. Hendrik Luesch, University of Florida
  “The functional interplay of marine natural products: marine cyanobacterial small molecules
  as activators of secondary metabolism in marine actinobacteria”
• Dr. Luke Norton, University of Texas Health Science Center at San Antonio
  “The Regulation of Hepatic Pyruvate Metabolism by Pioglitazone”
• Dr. Christina Pacak, University of Florida
  “Human Urinary Renal Epithelial Cells as Metabolic Biomarkers for Barth Syndrome”
• Dr. Mohan Raizada, University of Florida
  “Discovery of an Unique Bacterial Metabolic Profile in Resistant Hypertensive Patients”
• Dr. Stephanie Wohlgemuth, University of Florida
  “Effect of early gestational heat stress on the skeletal muscle metabolome in dairy cows”